Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$230M |
| 2 |
Johnson & Johnson
JNJ
|
+$205M |
| 3 |
Bank of America
BAC
|
+$163M |
| 4 |
Costco
COST
|
+$162M |
| 5 |
GSK
GSK
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$396M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$219M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Walt Disney
DIS
|
+$154M |
| 5 |
Amazon
AMZN
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.36% |
| 2 | Healthcare | 13.06% |
| 3 | Consumer Discretionary | 12.03% |
| 4 | Consumer Staples | 11.17% |
| 5 | Industrials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LEAP
426
DELISTED
LEAP WIRELESS INTERNATIONAL INC NEW
LEAP
| $22.1M | 0.05% |
1,271,137
+103,037
| +9% | +$1.69M |
|
427
Range Resources
RRC
$9.33B
| $21.9M | 0.05% |
260,350
-336,600
| -56% | -$26.2M |
|
428
Bankunited
BKU
$3.41B
| $21.9M | 0.05% |
666,400
-67,600
| -9% | -$2.15M |
|
429
Omega Healthcare
OHI
$13.9B
| $21.7M | 0.05% |
729,800
-510,500
| -41% | -$16.2M |
|
430
Allstate
ALL
$65.9B
| $21.7M | 0.05% |
398,300
-1,032,900
| -72% | -$55.1M |
|
431
Keurig Dr Pepper
KDP
$42.3B
| $21.7M | 0.05% |
+445,100
| New | +$21M |
|
432
Zebra Technologies
ZBRA
$18B
| $21.6M | 0.05% |
400,031
+42,700
| +12% | +$2.14M |
|
|
CKEC
433
DELISTED
Carmike Cinemas Inc
CKEC
| $21.6M | 0.05% |
775,600
+34,400
| +5% | +$817K |
|
434
Donaldson
DCI
$11.1B
| $21.6M | 0.05% |
495,998
-173,602
| -26% | -$7.07M |
|
435
American States Water
AWR
$3.52B
| $21.5M | 0.05% |
748,500
+14,100
| +2% | +$397K |
|
436
Carriage Services
CSV
$555M
| $21.4M | 0.05% |
1,097,100
+105,862
| +11% | +$2.01M |
|
|
ETP
437
DELISTED
Energy Transfer Partners, L.P.
ETP
| $21.4M | 0.05% |
567,022
-374,564
| -40% | -$12.9M |
|
438
Cal-Maine
CALM
$3.87B
| $21.4M | 0.05% |
710,000
-63,236
| -8% | -$1.68M |
|
439
US Physical Therapy
USPH
$1.24B
| $21.1M | 0.05% |
599,000
+28,300
| +5% | +$926K |
|
440
PG&E
PCG
$38.5B
| $21.1M | 0.05% |
+522,900
| New | +$21.4M |
|
441
EOG Resources
EOG
$74.2B
| $21M | 0.05% |
+250,800
| New | +$21.5M |
|
442
Brown-Forman Class B
BF.B
$12.9B
| $21M | 0.05% |
868,750
-1,154,766
| -57% | -$27.1M |
|
|
MODV
443
DELISTED
ModivCare
MODV
| $21M | 0.05% |
816,000
+15,600
| +2% | +$432K |
|
|
KRFT
444
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $20.9M | 0.05% |
+387,500
| New | +$20.7M |
|
445
Ashland
ASH
$3.36B
| $20.8M | 0.05% |
437,569
-75,220
| -15% | -$3.36M |
|
|
LVLT
446
DELISTED
Level 3 Communications Inc
LVLT
| $20.7M | 0.05% |
+625,021
| New | +$18.4M |
|
447
Iron Mountain
IRM
$37.7B
| $20.7M | 0.05% |
737,287
-1,411,252
| -66% | -$36.2M |
|
|
VR
448
DELISTED
Validus Hold Ltd
VR
| $20.7M | 0.05% |
+512,969
| New | +$20M |
|
|
CNQR
449
DELISTED
CONCUR TECHNOLOGIES INC
CNQR
| $20.6M | 0.05% |
199,940
+176,900
| +768% | +$17.9M |
|
450
Stagwell
STGW
$2.28B
| $20.6M | 0.05% |
807,800
+384,500
| +91% | +$8.33M |
|
Similar funds
Jim Simons's Q4 2013 Portfolio in Review
As of Q4 2013, Jim Simons held 3,281 positions worth $41.8B, up 1.3% from $41.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons withdrew a net $2.31B in Q4 2013, closing 464 positions and reducing 983 holdings. Its most notable exit was GE Aerospace, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Pfizer worth $230M.
- Jim Simons's largest Q4 2013 buy was Pfizer: 7,904,832 shares worth $230M.
- Jim Simons added most to Johnson & Johnson in Q4 2013, an estimated $205M increase.
- Jim Simons's biggest Q4 2013 reduction was IBM, cutting an estimated $396M.
- Jim Simons fully exited GE Aerospace in Q4 2013, selling an estimated $156M.
- Jim Simons's ten largest holdings make up 11% of its $41.8B portfolio in Q4 2013.
- Jim Simons opened 498 new positions and closed 464 in Q4 2013.
- Jim Simons's portfolio value rose 1.3% quarter-over-quarter to $41.8B.
Based on Renaissance Technologies's 13F filing for Q4 2013, filed 14 Feb 2014.